Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 56, 2022 - Issue 3
Journal homepage
1,653
Views
0
CrossRef citations to date
0
Altmetric
Articles

Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study

Eugen Y. H. Wanga Center for Clinical Research, Uppsala University, Sörmland, Sweden;b Department of Surgical Sciences, Uppsala University, Urology, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1825-8547View further author information
ORCID Icon,
Nicklas Pihlströma Center for Clinical Research, Uppsala University, Sörmland, SwedenView further author information
,
Per-Uno Malmströmb Department of Surgical Sciences, Uppsala University, Urology, SwedenView further author information
&
Truls Gårdmarkc Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0003-4610-0771View further author information
ORCID Icon
Pages 221-226 | Received 28 Sep 2021, Accepted 30 Mar 2022, Published online: 16 May 2022

References

  • Rieken M, Xylinas E, Kluth L, et al. Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder. Eur Urol. 2014;65(1):201–209.
  • Balan D, Martha O, Chibelean CB, et al. Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors. Medicine (Baltimore). 2018;97(16):e0522.
  • Wang EY, Larsson U, Gårdmark T, et al. Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer - is there a long-term survival difference? A Swedish nationwide analysis. Scand J Urol. 2021;55(1):46–52.
  • Gårdmark T, Bladström A, Hellsten S, et al. Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001. Scand J Urol Nephrol. 2006;40(4):276–282.
  • Liedberg F, Hagberg O, Holmäng S, et al. Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study. Scand J Urol. 2015;49(4):290–295.
  • Häggström C, Liedberg F, Hagberg O, et al. Cohort profile: the Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe). BMJ Open. 2017;7(9):e016606.
  • Erikson MS, Petersen AC, Andersen KK, et al. National incidence and survival of patients with non-invasive papillary urothelial carcinoma: a Danish population study. Scand J Urol. 2018;52(5–6):364–370.
  • Holmäng S, Hedelin H, Anderström C, et al. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol. 1995;153(6):1823–1826.
  • Cambier S, Sylvester RJ, Collette L, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance Bacillus Calmette-Guérin. Eur Urol. 2016;69(1):60–69.
  • Sörenby A, Baseckas G, Bendahl PO, et al. Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients. Scand J Urol. 2019;53(2–3):109–115.
  • Malmström PU, Grabe M, Haug ES, et al. Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance. Scand J Urol Nephrol. 2012;46(2):108–116.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.